Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00860379 · ClinicalTrials.gov registry record · Phase 4
The Effect of Selenium Supplementation Among Pediatric Patients With Burns
A Phase 4 study, sponsored by Shriners Hospitals for Children.
- Terminated
- Registry status
- Phase 4
- Development phase
- 14
- Enrollment target
NCT00860379 is a Phase 4 study that was terminated before completion, run by Shriners Hospitals for Children. The registered enrollment target is 14 participants.
The verdict
NCT00860379, a Phase 4 study, was terminated before completion, sponsored by Shriners Hospitals for Children.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 14 participants
- Enrollment target
Study Summary
The selenium status of children with major burns is suboptimal which may increase the incidence of infection. Se requirements during critical illness are not known. Results from this investigation may provide a tool for recommending Se supplements during burn injury. The hypothesis of this research is that Se supplementation will restore the depressed Se status among children with burn injuries. The secondary hypothesis is that Se status is related to the incidence of infection among pediatric patients with burns.
Interventions
- DRUG Placebo
- DRUG Selenium1
- DRUG Selenium2
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 14 participants |
| Start Date | 2009-01 |
| Est. Completion | 2019-12 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00860379
The ClinicalTrials.gov registry entry for NCT00860379 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 14 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Shriners Hospitals for Children, which has 40 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Placebo is the first listed.
NCT00860379 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00860379 about?
NCT00860379 is a clinical study titled "The Effect of Selenium Supplementation Among Pediatric Patients With Burns". The selenium status of children with major burns is suboptimal which may increase the incidence of infection. Se requirements during critical illness are not known. Results from this investigation may provide a tool for recommending Se supplements during burn injury. The hypothesis of this research...
What is the current status of trial NCT00860379?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 14 participants. The study started on 2009-01. Estimated completion is 2019-12.
What interventions are being tested in trial NCT00860379?
The interventions under investigation include: Placebo (DRUG), Selenium1 (DRUG), Selenium2 (DRUG).
Who is sponsoring clinical trial NCT00860379?
This trial is sponsored by Shriners Hospitals for Children, which has 40 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.